SCPHARMACEUTICALS INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
SCPHARMACEUTICALS INC. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $147.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-03-19
- SCPHARMACEUTICALS INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $147.00K, a 44.12% increase from fiscal 2023.
- SCPHARMACEUTICALS INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $102.00K, a 20.93% decline from fiscal 2022.
- SCPHARMACEUTICALS INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $129.00K, a 36.45% decline from fiscal 2021.
- SCPHARMACEUTICALS INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $203.00K, a 40.00% increase from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $147.00K 10-K · filed 2025-03-19 |
| 2023-12-31 | $102.00K 10-K · filed 2025-03-19 |
| 2022-12-31 | $129.00K 10-K · filed 2024-03-13 |
| 2021-12-31 | $203.00K 10-K · filed 2023-03-22 |
| 2020-12-31 | $145.00K 10-K · filed 2022-03-22 |
| 2019-12-31 | $152.00K 10-K · filed 2021-03-23 |
| 2018-12-31 | $146.00K 10-K · filed 2020-03-24 |
| 2017-12-31 | $125.00K 10-K · filed 2019-03-21 |
| 2016-12-31 | $74.00K 10-K · filed 2019-03-21 |